Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)

Chronic fatigue syndrome/ Myalgic encephalomyelitis (CFS/ME) is a poorly understood seriously debilitating disorder in which disabling fatigue is an universal symptom in combination with a variety of variable symptoms. The only drug in advanced clinical development is rintatolimod, a mismatched doub...

Descripción completa

Detalles Bibliográficos
Autor principal: Mitchell, William M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Drug Profile
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917909/
https://www.ncbi.nlm.nih.gov/pubmed/27045557
http://dx.doi.org/10.1586/17512433.2016.1172960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917909/
https://www.ncbi.nlm.nih.gov/pubmed/27045557
http://dx.doi.org/10.1586/17512433.2016.1172960

Ejemplares similares